| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0022 | 1 |